Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M99,163Revenue $M16,560Net Margin (%)9.8Altman Z-Score6.1
Enterprise Value $M101,218EPS $1.0Operating Margin %11.4Piotroski F-Score7
P/E(ttm)56.1Beneish M-Score-2.0Pre-tax Margin (%)13.1Higher ROA y-yN
Price/Book6.610-y EBITDA Growth Rate %-1.4Quick Ratio1.7Cash flow > EarningsY
Price/Sales6.05-y EBITDA Growth Rate %-14.3Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow94.3y-y EBITDA Growth Rate %-25.1ROA % (ttm)5.9Higher Current Ratio y-yY
Dividend Yield %2.5PEG--ROE % (ttm)12.9Less Shares Outstanding y-yN
Payout Ratio %140Shares Outstanding M1,668ROIC % (ttm)8.0Gross Margin Increase y-yY

Gurus Latest Trades with BMY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMYT Rowe Price Equity Income Fund 2015-12-31 Reduce-0.26%$59.88 - $70.71
($66.18)
$ 59.44-10%Reduce -18.01%4,520,000
BMYVanguard Health Care Fund 2015-12-31 Add0.12%$59.88 - $70.71
($66.25)
$ 59.44-10%Add 1.95%46,232,449
BMYKahn Brothers 2015-12-31 Reduce-0.01%$59.88 - $70.71
($66.25)
$ 59.44-10%Reduce -2.60%28,050
BMYKen Fisher 2015-12-31 Add0.01%$59.88 - $70.71
($66.18)
$ 59.44-10%Add 120.33%134,800
BMYMario Gabelli 2015-12-31 Reduce$59.88 - $70.71
($66.25)
$ 59.44-10%Reduce -1.85%639,355
BMYVanguard Health Care Fund 2015-09-30 Add0.21%$57.3 - $70.06
($63.44)
$ 59.44-6%Add 3.72%45,346,149
BMYT Rowe Price Equity Income Fund 2015-09-30 Reduce-0.08%$57.3 - $70.06
($63.44)
$ 59.44-6%Reduce -5.20%5,512,700
BMYMario Gabelli 2015-09-30 Reduce-0.01%$57.3 - $70.06
($63.44)
$ 59.44-6%Reduce -4.01%651,417
BMYGeorge Soros 2015-09-30 Buy 0.01%$57.3 - $70.06
($63.44)
$ 59.44-6%New holding5,000
BMYJoel Greenblatt 2015-09-30 Buy 0.01%$57.3 - $70.06
($63.44)
$ 59.44-6%New holding21,863
BMYRonald Muhlenkamp 2015-09-30 Add$57.3 - $70.06
($63.44)
$ 59.44-6%Add 0.06%211,750
BMYDodge & Cox 2015-09-30 Reduce$57.3 - $70.06
($63.44)
$ 59.44-6%Reduce -1.24%79,928
BMYKen Fisher 2015-09-30 Add$57.3 - $70.06
($63.44)
$ 59.44-6%Add 76.64%61,180
BMYVanguard Health Care Fund 2015-06-30 Add0.11%$63 - $69.15
($65.88)
$ 59.44-10%Add 1.90%43,718,751
BMYRonald Muhlenkamp 2015-06-30 Reduce-0.01%$63 - $69.15
($65.88)
$ 59.44-10%Reduce -0.26%211,620
BMYMario Gabelli 2015-06-30 Reduce-0.01%$63 - $69.15
($65.88)
$ 59.44-10%Reduce -3.66%678,636
BMYFirst Eagle Investment 2015-06-30 Reduce$63 - $69.15
($65.88)
$ 59.44-10%Reduce -8.05%13,325
BMYDodge & Cox 2015-06-30 Reduce$63 - $69.15
($65.88)
$ 59.44-10%Reduce -7.86%80,928
BMYKahn Brothers 2015-06-30 Add$63 - $69.15
($65.88)
$ 59.44-10%Add 1.41%28,800
BMYKen Fisher 2015-06-30 Add$63 - $69.15
($65.88)
$ 59.44-10%Add 6.77%34,636
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ANDREOTTI LAMBERTODirector 2016-01-05Sell23,200$67.56-12.02view
ANDREOTTI LAMBERTODirector 2015-12-15Sell23,200$69.03-13.89view
ANDREOTTI LAMBERTODirector 2015-11-20Sell23,200$67.39-11.8view
ANDREOTTI LAMBERTODirector 2015-10-06Sell23,200$60.86-2.33view
ANDREOTTI LAMBERTODirector 2015-09-03Sell23,200$59.40.07view
ANDREOTTI LAMBERTODirector 2015-08-03Sell315,000$65.36-9.06view
Caldarella Joseph CSVP & Controller 2015-06-04Sell16,972$65.71-9.54view
Schmukler Louis SPres., Global Mfg. & Supply 2015-03-16Sell12,000$66.96-11.23view
Cuss Francis MEVP & CSO 2015-03-16Sell114,666$67.81-12.34view
Moed Samuel JSVP, Strat Plan & Analysis 2015-03-13Sell591$66.67-10.84view

Press Releases about BMY :

Quarterly/Annual Reports about BMY:

News about BMY:

Articles On GuruFocus.com
10 Fund Managers Are Totally Wrong on GlaxoSmithKline Jan 26 2016 
5 Top Stocks of the Outperforming Vanguard Health Care Fund Dec 28 2015 
Designing the Appropriate Common Stock Retirement Portfolio: Stock Selection Options Part 1 Sep 14 2015 
Weekly Insider Sells Highlight: IMS, NOW, BMY, EA Aug 11 2015 
Will Bill Ackman Go After Express Scripts Next? Jun 30 2015 
Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
Abbvie Inc. Dividend Stock Analysis May 26 2015 
Baxter Takes The Acquisition Route To Grow In The Oncology Segment May 14 2015 
Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio May 07 2015 
Vanguard Adds to Four of Its Largest Stakes May 04 2015 

More From Other Websites
BRISTOL MYERS SQUIBB CO Files SEC form 10-K, Annual Report Feb 12 2016
How Long Will Bristol-Myers Squibb Continue to Decline? Feb 11 2016
Short Sellers Increase Bets in Major Pharma Feb 10 2016
Bristol-Myers Squibb Is Ready to Lead Again: Must-See Charts Feb 09 2016
Bristol-Myers' Daklinza-Sovaldi Label Expanded by the FDA Feb 08 2016
Where is Ronald Reagan When You Need Him? Feb 08 2016
U.S. FDA Approves Expanded Use of Bristol-Myers Squibb’s Daklinza (daclatasvir) for Additional... Feb 05 2016
Growth, Factors at Play - Analyst Notes on General Electric, Dow Chemical, Bristol-Myers Squibb and... Feb 04 2016
Bristol-Myers Squibb to Take Part in Leerink Swann Global Healthcare Conference Feb 03 2016
Merck gives cautious 2016 outlook as sales of top medicines lag Feb 03 2016
Pfizer earnings fall but tops Street 4Q forecasts Feb 02 2016
Pfizer earnings fall but tops Street 4Q forecasts Feb 02 2016
Bristol-Myers Squibb Co. Earnings Analysis: Q4, 2015 By the Numbers Feb 02 2016
Bristol-Myers Squibb Foundation Awards Eight Grants Totaling Nearly $11.5M to Make Lung and Skin... Feb 01 2016
Bristol-Myers Squibb Foundation Awards Eight Grants Totaling Nearly $11.5M to Make Lung and Skin... Feb 01 2016
Technical Pointers on Drug Manufacturers - Major Stocks -- Bristol-Myers Squibb, Eli Lilly,... Feb 01 2016
Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and... Feb 01 2016
Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and... Feb 01 2016
Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and... Feb 01 2016
Adversity Creates Opportunity Feb 01 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK